Antioxidant treatment for lung diseases

Bibliography

• RAHMAN I: Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets. Curr. Drug Targets Inflamm. Allergy (2002) 1(3):291–315.
   PubMedGoogle Scholar
• COMHAIR SA, ERZURUM SC: Antioxidant responses to oxidant-mediated lung diseases. Am. J. Physiol. Lung Cell Md. Physiol. (2002) 283(2):L246–L255.
   Google Scholar
• BRIGHAM KL: Role of free radicals in lung injury. Chest (1986) 89(6):859–863.
   PubMedGoogle Scholar
• MASELLI R, GREMBIALE RD, PELAIA G, CUDA G: Oxidative stress and lung diseases. Monaldi Arch. Chest Dis. (2002) 57(3-4):180–181.
   PubMedGoogle Scholar
• KINNULA VL, CRAPO JD: Superoxide dismutases in the lung and human lung diseases. Am. J. Respir. Crit. Care Med. (2003) 167(12):1600–1619.
   PubMed Web of Science ®Google Scholar
• WU W, SAMOSZUK MK, COMHAIR SA et al.: Eosinophils generate brominating oxidants in allergen-induced asthma. J. Clin. Invest. (2000) 105(10):1455–1463.
   PubMed Web of Science ®Google Scholar
• CANTIN AM, NORTH SL, HUBBARD RC, CRYSTAL RG: Normal alveolar epithelial lining fluid contains high levels of glutathione. J. Appl. Physiol (1987) 63(1):152–157.
   PubMed Web of Science ®Google Scholar
• RAHMAN I, MACNEE W: Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am. J. Physiol (1999) 277(6, Pt.1):L1067–L1088.
   Google Scholar
• RAHMAN I, BIS WAS SK, JIMENEZ LA, TORRES M, JAY FH: Glutathione, stress responses, and redox signaling in lung inflammation. Anti oxid. Redox Signal. (2005) 7(1-2):42–59.
   PubMed Web of Science ®Google Scholar
• MINKO T, STEFANOV A, POZHAROV V: Selected contribution: lung hypoxia: antioxidant and antiapoptotic effects of liposomal a-tocopherol. j Appl. Physiol (2002) 93(4):1550–1560.
   PubMedGoogle Scholar
• HADDAD JJ: Science review: redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for nuclear factor-KB. Crit. Care (2002) 6(6):481–490.
   PubMedGoogle Scholar
• HADDAD JJ: Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell. Signal. (2002) 14(11):879–897.
   PubMed Web of Science ®Google Scholar
• CRAPO JD: Oxidative stress as an initiator of cytokine release and cell damage. Eur. Respir. j Suppl (2003) 44:4s–6s.
   Google Scholar
• BOWLER RP, CRAPO JD: Oxidative stress in allergic respiratory diseases. J. Allergy Clin. Immunol (2002) 110(3):349–356.
   PubMedGoogle Scholar
• MASELLI R, GREMBIALE RD, PELAIA G, CUDA G: Oxidative stress and lung diseases. Monaldi Arch. Chest Dis. (2002) 57(3-4):180–181.
   PubMedGoogle Scholar
• DEKHUIJZEN PN: Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur. Respir. J. (2004) 23(4):629–636.
   PubMed Web of Science ®Google Scholar
• MARNETT LJ: Oxyradicals and DNA damage. Carcinogenesis (2000) 21(3):361–370.
   PubMedGoogle Scholar
• BARNES PJ, ADCOCK IM, ITO K: Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur. Respir. J. (2005) 25(3):552–563.
   PubMed Web of Science ®Google Scholar
• BM C, BROWN LA, JONES DP: Glutathione transport by Type II cells in perfitsed rat lung. Am. J. PhysioL (1994) 267(4, Pt.1):L447–L455.
   Google Scholar
• MARRADES RM, ROCA J, BARBERA JA, DE JOVER L, MACNEE W, RODRIGUEZ-ROISIN R: Nebulized glutathione induces bronchoconstriction in patients with mild asthma. Am. J. Respir. Crit. Care Med. (1997) 156(2, Pt.1):425–430.
   Google Scholar
• BRIDGEMAN MM, MARSDEN M, SELBY C, MORRISON D, MACNEE W: Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax (1994) 49(7):670–675.
   PubMed Web of Science ®Google Scholar
• GUIDOT DM, BROWN LA: Mitochondrial glutathione replacement restores surfactant synthesis and secretion in alveolar epithelial cells of ethanol-fed rats. Alcohol Clin. Exp. Res. (2000) 24(7):1070–1076.
   PubMedGoogle Scholar
• BUTTERWORTH M, UPSHALL DG, HOBBS M, COHEN GM: Elevation of cysteine and replenishment of glutathione in rat lung slices by cysteine isopropylester and other cysteine precursors. Biochem. Pharmacol (1993) 45(9):1769–1774.
   PubMedGoogle Scholar
• MACNEE W, RAHMAN I: Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am. Respir. Crit. Care Med. (1999) 160(5, Pt.2):558–565.
   Google Scholar
• LINKS M, LEWIS C: Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy. Drugs (1999) 57(3):293–308.
   PubMed Web of Science ®Google Scholar
• JOHNSON DH: Overview of ifosfamide in small cell and non-small cell lung cancer. Semin. Oncol (1990) 17(2, Supp1.4):24–30.
   Google Scholar
• ANTONICELLI F, PARMENTIER M, DROST EM et al.: Nacystelyn inhibits oxidant-mediated interleukin-8 expression and NF-KB nuclear binding in alveolar epithelial cells. Free Radic. Biol. Med. (2002) 32(6):492–502.
   PubMedGoogle Scholar
• APP EM, BARAN D, DAB I et ell.: Dose-finding and 24 h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis. Eur. Respir. J. (2002) 19(2):294–302.
   Google Scholar
• RATHBUN WB, KILLEN CE, HOLLESCHAU AM, NAGASAWA HT: Maintenance of hepatic glutathione homeostasis and prevention of acetaminophen-induced cataract in mice by L-cysteine prodrugs. Biochem. PharmacoL (1996) 51(9):1111–1116.
   PubMedGoogle Scholar
• ROBERTS JC, CHARYULU RI,, ZERA RT, NAGASAWA HT: Protection against acetaminophen hepatotoxicity by ribose-cysteine (RibCys). PharmacoL Toxicol (1992) 70(4):281–285.
   PubMedGoogle Scholar
• FRICKE RF, JORGE J: Methylthiazolidine-4-carboxylate for treatment of acute T-2 toxin exposure. J. App/. Toxica (1991) 11(2):135–140.
   PubMedGoogle Scholar
• O'NEILL IK, OHSHIMA H: Roles of cysteine as both precursor of thiazolidine 4-carboxylic acids found in human urine and possible inhibitor of endogenous N-nitrosation. IARC Sci. PubL (1987) 84:322–327.
   Google Scholar
• MASINI E, BANI D, VANNACCI A et ell.: Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic. Free Radic. Biol. Med. (2005) 39(4):520–531.
   Google Scholar
• IZUMI M, MCDONALD MC, SHARPE MA, CHATTERJEE PK, THIEMERMANN C: Superoxide dismutase mimetics with catalase activity reduce the organ injury in hemorrhagic shock. Shock (2002) 18(3):230–235.
   PubMedGoogle Scholar
• CUT X, PARENT C, MACARTHUR H et al.: Severity of sepsis alters the effects of superoxide anion inhibition in a rat sepsis model. J. Appl. PhysioL (2004) 97(4):1349–1357.
   PubMedGoogle Scholar
• KACHADOURIAN R, FLAHERTY MM, CRUMBLISS AL, PATEL M, DAY BJ: Synthesis and in vitro antioxidant properties of manganese(III) 0-octabromo-meso-tetrakis(4-carboxyphenypporphyrin. Inorg Biochem. (2003) 95(4):240–248.
   PubMedGoogle Scholar
• PATEL M, DAY BJ: Metalloporphyrin class of therapeutic catalytic antioxidants. Trends PharmacoL Sci. (1999) 20(9):359–364.
   PubMedGoogle Scholar
• CHANG LY, SUBRAIVIANIAM M, YODER BA et al.: A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. (2003) 167(1):57–64.
   PubMedGoogle Scholar
• CRACOWSKI JL, CRACOWSKI C, BESSARD G et al.: Increased lipid peroxidation in patients with pulmonary hypertension. Am. J. Respir. Crit. Care Med. (2001) 164(6):1038–1042.
   PubMed Web of Science ®Google Scholar
• HOSHIKAWAY, ONO S, SUZUKI S et al.: Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. J. Appl. Physiol (2001) 90(4):1299–1306.
   PubMedGoogle Scholar
• STEINHORN RH, ALBERT G, SWARTZ DD, RUSSELL JA, LEVINE CR, DAVIS JM: Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension. Am. J. Respir. Crit. Care Med. (2001) 164(5):834–839.
   PubMedGoogle Scholar
• BEEHARRY N, LOWE JE, HERNANDEZ AR et al.: Linoleic acid and antioxidants protect against DNA damage and apoptosis induced by palmitic acid. Mutat. Res. (2003) 530(1-2):27–33.
   PubMed Web of Science ®Google Scholar
• HANSEN NC, SKRIVER A, BRORSEN-RIIS Let al.: Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis. Respir. Med. (1994) 88(7):531–535.
   Google Scholar
• PELA R, CALCAGNI AM, SUBIACO S, ISIDORI P, TUBALDI A. SANGUINETTI CM: N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD. Respiration (1999) 66(6):495–500.
   Google Scholar
• BLACK PN, MORGAN-DAY A. MCMILLAN TE, POOLE PJ, YOUNG RP: Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]. BMC Pulm. Med. (2004) 4(1):13.
   PubMedGoogle Scholar
• TATTERSALL AB, BRIDGMAN KM, HUITSON A: Acetylcysteine (Fabrol) in chronic bronchitis - a study in general practice./ Int. Med. Res. (1983) 11(5):279–284.
   Google Scholar
• DECRAMER M, DEKHUIJZEN PN, TROOSTERS T et al.: The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design. BRONCUS-trial Committee. Eur. Respir. (2001) 17(3):329–336.
   PubMed Web of Science ®Google Scholar
• BEEH KM, BEIER J, HAAS IC, KORNMANN 0, MICKE P, BUHL R: Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis. Eur. Respir. J. (2002) 19(6):1119–1123.
   PubMedGoogle Scholar
• RAHMAN I, SKWARSKA E, HENRY M et al.: Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radic. Biol. Med. (1999) 27(1-2):60–68.
   PubMed Web of Science ®Google Scholar
• MEYER A, BUHL R, KAMPF S, MAGNUSSEN H: Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am. J. Respir. Crit. Care Med. (1995) 152(3):1055–1060.
   PubMed Web of Science ®Google Scholar
• BERNARD GR, WHEELER AP, ARONS MM et al.: A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest (1997) 112(1):164–172.
   Google Scholar
• SMIT HA, GRIEVINK L, TABAK C: Dietary influences on chronic obstructive lung disease and asthma: a review of the epidemiological evidence. Proc. Num. Soc. (1999) 58(2):309–319.
   PubMedGoogle Scholar
• COOK DG, CAREY IM, WHINCUP PH et al.: Effect of fresh fruit consumption on lung function and wheeze in children. Thorax (1997) 52(7):628–633.
   PubMedGoogle Scholar
• FORASTIERE F, PISTELLI R, SESTINI P et al.: Consumption of fresh fruit rich in vitamin C and wheezing symptoms in children. SIDRIA Collaborative Group, Italy (Italian Studies on Respiratory Disorders in Children and the Environment). Thorax (2000) 55(4):283–288.
   Google Scholar
• SCHWARTZ J, WEISS ST: Dietary factors and their relation to respiratory symptoms. The Second National Health and Nutrition Examination Survey. Am. J. Epidemiol (1990) 132(1):67–76.
   Google Scholar
• SCHWARTZ J, WEISS ST: Relationship between dietary vitamin C intake and pulmonary function in the First National Health and Nutrition Examination Survey (NHANES I). Am. J. Clin. Num. (1994) 59(1):110–114.
   PubMed Web of Science ®Google Scholar
• ROMIEU I, MANNINO DM, REDD SC, MCGEEHIN MA: Dietary intake, physical activity, body mass index, and childhood asthma in the Third National Health And Nutrition Survey (NHANES III). Pediam. Pulmonol (2004) 38(1):31–42.
   PubMedGoogle Scholar
• OLUSI SO, OJUTIKU 00, JESSOP WJ, IBOKO MI: Plasma and white blood cell ascorbic acid concentrations in patients with bronchial asthma. Clin. Chim. Acta (1979) 92(2):161–166.
   PubMedGoogle Scholar
• KELLY FJ, MUD WAY I, BLOMBERG A, FREW A, SANDSTROM T: Altered lung antioxidant status in patients with mild asthma. Lancet (1999) 354(9177):482–483.
   PubMed Web of Science ®Google Scholar
• RAM FS, ROWE BH, KAUR B: Vitamin C supplementation for asthma. Cochrane Database Syst. Rev. (2004) 3:CD000993.
   Google Scholar
• COHEN HA, NEUMAN I, NAHUM H: Blocking effect of vitamin C in exercise-induced asthma. Arch. Pediam. Adolesc. Med. (1997) 151(4):367–370.
   PubMedGoogle Scholar
• ZUSKIN E, LEWIS AJ, BOUHUYS A: Inhibition of histamine-induced airway constriction by ascorbic acid./ Allergy Clin. Immunol (1973) 51(4):218–226.
   Google Scholar
• MOHSENIN V, DUBOIS AB, DOUGLAS JS: Effect of ascorbic acid on response to methacholine challenge in asthmatic subjects. Am. Rev. Respir. Dis. (1983) 127(2):143–147.
   PubMedGoogle Scholar
• PEARSON PJ, LEWIS SA, BRITTON J, FOGARTY A: Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial. Thorax (2004) 59(8):652–656.
   PubMed Web of Science ®Google Scholar
• ROMIEU I, SIENRA-MONGE JJ, RAMIREZ-AGUILAR M et al.: Antioxidant supplementation and lung functions among children with asthma exposed to high levels of air pollutants. Am. Respir. Crit. Care Med. (2002) 166(5):703–709.
   PubMedGoogle Scholar
• TRENGA CA, KOENIG JQ, WILLIAMS PV: Dietary antioxidants and ozone-induced bronchial hyperresponsiveness in adults with asthma. Arch. Environ. Health (2001) 56(3):242–249.
   PubMedGoogle Scholar
• TABAK C, ARTS IC, SMIT HA, HEEDERIK D, KROMHOUT D: Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN Study. Am. J. Respir. Crit. Care Med. (2001) 164(1):61–64.
   PubMedGoogle Scholar
• STRACHAN DP, COX BD, ERZINCLIOGLU SW, WALTERS DE, WHICHELOW MJ: Ventilatory function and winter fresh fruit consumption in a random sample of British adults. Thorax (1991) 46(9):624–629.
   PubMedGoogle Scholar
• BRITTON JR, PAVORD ID, RICHARDS KA et al.: Dietary antioxidant vitamin intake and lung function in the general population. Am. J. Respir. Crit. Care Med. (1995) 151(5):1383–1387.
   PubMed Web of Science ®Google Scholar
• GRIEVINK L, SMIT HA, OCKE MC, VAN V, KROMHOUT D: Dietary intake of antioxidant (pro)-vitamins, respiratory symptoms and pulmonary function: the MORGEN study. Thorax (1998) 53(3):166–171.
   PubMed Web of Science ®Google Scholar
• MIEDEMA I, FESKENS EJ, HEEDERIK D, KROMHOUT D: Dietary determinants of long-term incidence of chronic nonspecific lung diseases. The Zutphen Study. Am. J. Epidemiol. (1993) 138(1):37–45.
   PubMedGoogle Scholar
• SCHMIDT R, LUBOEINSKI T, MARKART P et al.: Alveolar antioxidant status in patients with acute respiratory distress syndrome. Eur. Respir. J. (2004) 24(6):994–999.
   PubMedGoogle Scholar
• METNITZ PG, BARTENS C, FISCHER M, FRIDRICH P, STELTZER H, DRUML W: Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med. (1999) 25(2):180–185.
   PubMed Web of Science ®Google Scholar
• NATHENS AB, NEFF MJ, JURKOVICH GJ et al.: Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann. Surg. (2002) 236(0:814–822.
   PubMedGoogle Scholar
• NELSON JL, DEMICHELE SJ, PACHT ER, WENNBERG AK: Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. J. Parenter. Enteral Nutr. (2003) 27(2):98–104.
   PubMedGoogle Scholar
• ROMIEU I, TRENGA C: Diet and obstructive lung diseases. Epidemiol. Rev. (2001) 23(2):268–287.
   PubMed Web of Science ®Google Scholar
• HATCH GE: Asthma, inhaled oxidants, and dietary antioxidants. Am. J. Clin. Nutr. (1995) 61(3 Suppl.):6255–6305.
   Google Scholar
• OMENN GS, GOODMAN G, THORNQUIST M et al.: The 0-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res. (1994) 54\(Supp1.7):2038s–2043s.
   Google Scholar
• NO AUTHORS LISTED: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The a-Tocopherol, 0-Carotene Cancer Prevention Study Group. N Engl Med. (1994) 330(15):1029–1035.
   Google Scholar
• PAOLINI M, ABDEL-RAHMAN SZ, SAPONE A et al.: 0-Carotene: a cancer chemopreventive agent or a co-carcinogen? Mutat. Res. (2003) 543(3):195–200.
   Google Scholar
• RAUTALAHTI M, VIRTAMO J, HAUKKA J et al.: The effect of a-tocopherol and 0-carotene supplementation on COPD symptoms. Am. J. Respir. Crit. Care Med. (1997) 156(5):1447–1452.
   PubMed Web of Science ®Google Scholar
• VIGNAIS PV: The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell. Mol. Life Sci. (2002) 59(9):1428–1459.
   PubMed Web of Science ®Google Scholar
• BRAR SS, KENNEDY TP, STURROCK AB et al.: NADPH oxidase promotes NF-4(13 activation and proliferation in human airway smooth muscle. Am. J. Physiol. Lung Cell Md. Physiol (2002) 282(4):L782–L795.
   Google Scholar
• JONES RD, HANCOCK JT, MORICE AH: NADPH oxidase: a universal oxygen sensor? Free Radic. Biol. Med. (2000) 29(5):416–424.
   Google Scholar
• THOMPSON JS, JONES RD, ROGERS TK, HANCOCK J, MORICE AH: Inhibition of hypoxic pulmonary vasoconstriction in isolated rat pulmonary arteries by diphenyleneiodonium (DPI). Pulm. Pharmacol Ther. (1998) 11(1):71–75.
   PubMedGoogle Scholar
• DODD 0, PEARSE DB: Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury. Am. J. Physiol Heart Circ. Physiol. (2000) 279(1):H303–H312.
   Google Scholar
• PEARSE DB, DODD JM: Ischemia-reperfusion lung injury is prevented by apocynin, a novel inhibitor of leukocyte NADPH oxidase. Chest (1999) 116\(Supp1.1):555–565.
   Google Scholar
• RITSICK DR, LAMBETH JD: Spring brings breezes, wheezes, and pollen oxiciases. j Clin. Invest. (2005) 115(8):2067–2069.
   PubMedGoogle Scholar
• PETERS EA, HILTERMANN JT, STOLK J: Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics. Free Radic. Biol. Med. (2001) 31(11):1442–1447.
   PubMed Web of Science ®Google Scholar
• MCCORD JM, FRIDOVICH I: The reduction of cytochrome c by milk xanthine oxidase. J. Biol Chem. (1968) 243(21):5753–5760.
   PubMed Web of Science ®Google Scholar
• GUIDOT DM, MCCORD JM, WRIGHT RM, REPINE JE: Absence of electron transport (Rho 0 state) restores growth of a manganese-superoxide dismutase-deficient Saccharomyces cerevisiae in hyperoxia. Evidence for electron transport as a major source of superoxide generation in vivo. J. Biol Chem. (1993) 268(35):26699–26703.
   Google Scholar
• GUIDOT DM, REPINE JE, KITLOWSKI AD et al.: Mitochondrial respiration scavenges extramitochondrial superoxide anion via a nonenzymatic mechanism. j Clin. Invest. (1995) 96(2):1131–1136.
   PubMed Web of Science ®Google Scholar
• GUIDOT DM: Endotoxin pretreatment in vivo increases the mitochondrial respiratory capacity in rat hepatocytes. Arch. Biochem. Biophys. (1998) 354(1):9–17.
   PubMedGoogle Scholar
• OMAR BA, GAD NM, JORDAN MC et al.: Cardioprotection by Cu,Zn-superoxide dismutase is lost at high doses in the reoxygenated heart. Free Radic. Biol Med. (1990) 9(6):465–471.
   PubMed Web of Science ®Google Scholar
• NELSON SK, BOSE SK, MCCORD JM: The toxicity of high-dose superoxide dismutase suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfitsed heart. Free Radic. Biol. Med. (1994) 16(2):195–200.
   PubMedGoogle Scholar
• GRONER Y, ELROY-STEIN 0, AVRAHAIVI KB et al: Cell damage by excess CuZnSOD and Down's syndrome. Biomed. Pharmacother . (1994) 48(5-6):231–240.
   PubMedGoogle Scholar
• ORTOLANI 0, CONTI k DE GAUDIO AR, MASONI M, NOVELLI G: Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome. Shock (2000) 13(1):14–18.
   PubMed Web of Science ®Google Scholar
• JEPSEN S, HERLEVSEN P, KNUDSEN P, BUD MI, KLAUSEN NO: Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study. Crit. Care Med. (1992) 20(7):918–923.
   PubMed Web of Science ®Google Scholar
• DECRAMER M, RUTTEN -VAN MOLKEN M, DEKHUIJZEN PN et al.: Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet (2005) 365(9470):1552–1560.
   Google Scholar
• SZKUDLAREK U, ZDZIECHOWSKI A, -WITKOWSKI K et aL: Effect of inhaled N-acetylcysteine on hydrogen peroxide exhalation in healthy subjects. Pulm. PharmacoL Ther. (2004) 17(3):155–162.
   PubMed Web of Science ®Google Scholar
• PELA R, CALCAGNI AM, SUBIACO S, ISIDORI P, TUBALDI A. SANGUINETTI CM: N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD. Respiration (1999) 66(6):495–500.
   Google Scholar
• CHIKINA SI, IAGMUROV BK, KOPYLEV ID, SOODAEVA SK, CHUCHALIN AG: [N-Acetylcysteine: low and high doses in the treatment of chronic obstructive lung diseases in Chernobyl accident liquidators]. Ter. Arkh. (2002) 74(3):62–65.
   PubMedGoogle Scholar
• LUKAS R, SCHARLING B, SCHULTZE-WERNINGHAUS G, GILLISSEN A: [Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis]. Dtsch. Med. Wochenschr. (2005) 130(11):563–567.
   PubMedGoogle Scholar
• HABIB MP, TANK LJ, LANE LC, GAREWAL HS: Effect of vitamin E on exhaled ethane in cigarette smokers. Chest (1999) 115(3):684–690.
   PubMedGoogle Scholar
• GRIESE M, RAIVIAKERS J, KRASSELT A et al.: Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am. J. Respir. Crit. Care Med. (2004) 169(7):822–828.
   PubMed Web of Science ®Google Scholar
• HARTL D, STAROSTA V, MATER K et al.: Inhaled glutathione decreases PGE, and increases lymphocytes in cystic fibrosis lungs. Free Radic. Biol. Med. (2005) 39(4):463–472.
   PubMed Web of Science ®Google Scholar
• STAFANGER G, KOCH C: N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: clinical score, spirometry and ciliary motility. Eur. Respir. J. (1989) 2(3):234–237.
   PubMedGoogle Scholar
• RATJEN F, WONNE R, POSSELT HG, STOVER B, HOFMANN D, BENDER SW: A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis. Eur. j Pediatr. (1985) 144(4):374–378.
   PubMedGoogle Scholar
• WOOD LG, FITZGERALD DA, LEE AK, GARG ML: Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am. J. Clin. Num. (2003) 77(1):150–159.
   PubMedGoogle Scholar
• RUST P, EICHLER I, RENNER S, ELMADFA I: Effects of long-term oral 0-carotene supplementation on lipid peroxiciation in patients with cystic fibrosis. Int. J. Vitam. Num. Res. (1998) 68(2):83–87.
   Google Scholar
• COBANOGLU N, OZCELIK U, GOCMEN A, KIPER N, DOGRU D: Antioxidant effect of 0-carotene in cystic fibrosis and bronchiectasis: clinical and laboratory parameters of a pilot study. Acta Paediatr. (2002) 91(7):793–798.
   PubMed Web of Science ®Google Scholar
• LEPAGE G, CHAMPAGNE J, RONCO N et al.: Supplementation with carotenoids corrects increased lipid peroxiciation in children with cystic fibrosis. Am. J. Clin. Num. (1996) 64(1):87–93.
   PubMed Web of Science ®Google Scholar
• WINKLHOFER-ROOB BM, VAN 'T HOF MA, SHMERLING DH: Response to oral 0-carotene supplementation in patients with cystic fibrosis: a 16-month follow-up study. Acta Paediatr. (1995) 84(10):1132–1136.
   PubMedGoogle Scholar
• MEYER A, BUHL R, MAGNUSSEN H: The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur. Respir. J. (1994) 7(3):431–436.
   PubMed Web of Science ®Google Scholar
• BEHR J, MATER K, DEGENKOLB B, KROMBACH F, VOGELMEIER C: Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am. J. Respir. Crit. Care Med. (1997) 156(6):1897–1901.
   PubMed Web of Science ®Google Scholar
• BOROK Z, BUHL R, GRIMES GJ et ed.: Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet (1991) 338(8761):215–216.
   Google Scholar
• BEHR J, DEGENKOLB B, KROMBACH F, VOGELMEIER C: Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine. Eur. Respir. J. (2002) 19(5):906–911.
   PubMed Web of Science ®Google Scholar